197 related articles for article (PubMed ID: 33628817)
21. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
22. Tumor-suppressive activity of Hnf1β in Wilms' tumor.
Liu Y; Kanyomse Q; Xie Y
Biosci Biotechnol Biochem; 2019 Nov; 83(11):2008-2015. PubMed ID: 31038395
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
24. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
[TBL] [Abstract][Full Text] [Related]
26. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
27. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
28. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
[TBL] [Abstract][Full Text] [Related]
29. Glypican 3 overexpression in primary and metastatic Wilms tumors.
Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
Zhu KR; Sun QF; Zhang YQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
[TBL] [Abstract][Full Text] [Related]
32. Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.
Wu X; Feng R; Wang X; Guo F; Liu W
J Cancer Res Ther; 2021 Nov; 17(5):1281-1285. PubMed ID: 34850779
[TBL] [Abstract][Full Text] [Related]
33. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
35. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
[TBL] [Abstract][Full Text] [Related]
36. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
37. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
38. Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.
Liu L; Song Z; Gao XD; Chen X; Wu XB; Wang M; Hong YD
BMC Cancer; 2021 Mar; 21(1):316. PubMed ID: 33765954
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
40. The genetic changes of Wilms tumour.
Treger TD; Chowdhury T; Pritchard-Jones K; Behjati S
Nat Rev Nephrol; 2019 Apr; 15(4):240-251. PubMed ID: 30705419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
